You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cyclin D1 antibody [CD1.1] (ab6152)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab6152? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab6152 has been referenced in 10 publications.

  1. Wei W et al. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer 10:16 (2011). WB, IHC; Human. PubMed: 21314951
  2. Bimpaki EI et al. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur J Endocrinol 161:153-61 (2009). PubMed: 19429701
  3. Chen KM et al. Modulations of benzo[a]pyrene-induced DNA adduct, cyclin D1 and PCNA in oral tissue by 1,4-phenylenebis(methylene)selenocyanate. Biochem Biophys Res Commun 383:151-5 (2009). IHC-FoFr; Mouse. PubMed: 19344691
  4. Weinberger PM et al. Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. Arch Otolaryngol Head Neck Surg 135:694-703 (2009). PubMed: 19620592
  5. Stefancikova L et al. Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected. J Clin Pathol 62:948-50 (2009). WB; Human. PubMed: 19783727
  6. Ottewell PD et al. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 8:2821-32 (2009). WB; Mouse. PubMed: 19789217
  7. Psyrri A et al. Correlates and determinants of nuclear epidermal growth factor receptor content in an oropharyngeal cancer tissue microarray. Cancer Epidemiol Biomarkers Prev 17:1486-92 (2008). PubMed: 18559565
  8. Pohl G et al. Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutations. Cancer Res 65:1994-2000 (2005). PubMed: 15753399
  9. Yu Z et al. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. Clin Cancer Res 11:2471-7 (2005). PubMed: 15814622
  10. Yu Z et al. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res 11:1160-6 (2005). WB, IHC-P; Human. PubMed: 15709184

Publishing research using ab6152? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"